Medstar Georgetown Transplant Institute — Washington D.C., District of Columbia

Medstar Georgetown Transplant Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Medstar Georgetown Transplant Institute has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Chronic Kidney Diseases, Genetic Predisposition, Heart Transplant.

Sponsors: Northwestern University, National Institute of Allergy and Infectious Diseases (NIAID), Target PharmaSolutions, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medstar Georgetown Transplant Institute?

Medstar Georgetown Transplant Institute has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medstar Georgetown Transplant Institute conducted?

Medstar Georgetown Transplant Institute has 6 clinical trials on record, with 2 currently active. Their work covers Chronic Kidney Diseases, Genetic Predisposition, Heart Transplant.

Is Medstar Georgetown Transplant Institute accredited by Crixeo Health?

Yes — Medstar Georgetown Transplant Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Medstar Georgetown Transplant Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.